What's new

Human medicines European public assessment report (EPAR): Stoboclo, denosumab, Date of authorisation: 14/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR): Stoboclo, denosumab, Date of authorisation: 14/02/2025, Status: Authorised

Apr 4, 2025 - 14:53
 0
Human medicines European public assessment report (EPAR): Stoboclo, denosumab, Date of authorisation: 14/02/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Stoboclo, denosumab, Date of authorisation: 14/02/2025, Status: Authorised
Read More

Tags:

Previous Article

NIH hit with chaos, cuts, and contractor purge

Next Article

True Classic Secures Investment From 1686 Partners

Related Posts

Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 20/12/2021, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Ravicti, glycerol phenylbutyrate, Date of authorisation: 26/11/2015, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 18, 2025  0

Orphan designation: Magrolimab Treatment of myelodysplastic syndromes, 26/06/2020 Withdrawn

Orphan designation: Magrolimab Treatment of myelodyspla...

Mar 12, 2025  0